- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Common side effects of dimethyl fumarate in the treatment of multiple sclerosis include flushing, gastrointestinal reactions, and decreased l...
DimethylFumarate is an oral immunomodulatory agent used to treat recurrent multiple sclerosis (RMS), controlling disease progression through ...
As an SGLT2 inhibitor, the dosage and administration of Inpefa should be adjusted according to individual patient conditions. Special attention...
As an SGLT2 inhibitor, the side effects of Inpefa mainly involve the urinary and reproductive system, metabolism, and skin reactions, which can...
Serpatinib (Retevmo), as a highly selective RET inhibitor, has shown significant efficacy in the treatment of RET gene mutant tumors. At the sa...
Accidental overdose of Serpatinib (Retevmo) may cause serious adverse reactions, and graded treatment measures should be taken based on specifi...
Gilteritinib has significant therapeutic effects on FLT3 mutation positive AML patients, but the discontinuation process needs to be standardiz...
Gilteritinib is an FLT3 tyrosine kinase inhibitor primarily used to treat relapsed/refractory acute myeloid leukemia (AML) with FLT3 mutation p...
Blujepa, as an antibacterial drug, has specific contraindications, dietary restrictions, and medication constraints when used. The following pr...
The therapeutic effect of Blujepa needs to be evaluated based on specific indications, and its discontinuation process should follow a gradual ...
